5VM
TARA icon

5AM Venture Management’s Protara Therapeutics TARA Stock Holding History

5AM Venture Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.23M Hold
1,369,782
– – 1.82% 15
2026
Q1 		$7.14M Hold
1,369,782
– – 1.98% 15
2025
Q4 		$7.3M Buy
1,369,782
+569,782
+71% +$3.17M 2.3% 16
2025
Q3 		$3.48M Hold
800,000
– – 1.27% 19
2025
Q2 		$2.42M Hold
800,000
– – 0.93% 24
2025
Q1 		$3.41M Hold
800,000
– – 1.29% 23
2024
Q4 		$4.22M Buy
+800,000
New +$2.58M 1.01% 23

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

5AM Venture Management's TARA Position: Q2 2026 in Review

5AM Venture Management held its Protara Therapeutics (TARA) position steady in Q2 2026 at 1,369,782 shares worth $5.23M. The position accounts for 1.82% of the portfolio, ranked #15.

5AM Venture Management first reported a position in TARA in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.3M in Q4 2025. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • 5AM Venture Management held 1,369,782 shares of Protara Therapeutics worth $5.23M as of Q2 2026.
  • 5AM Venture Management left its Protara Therapeutics share count unchanged in Q2 2026.
  • Protara Therapeutics made up 1.82% of 5AM Venture Management's portfolio in Q2 2026, its #15 holding.
  • 5AM Venture Management first reported a position in Protara Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 5AM Venture Management's Protara Therapeutics position peaked at $7.3M in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on 5AM Venture Management's 13F filing for Q2 2026, filed 14 Aug 2026.